W. Suddath

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Frequency of conduction disturbances after transcatheter implantation of an Edwards SAPIEN aortic valve prosthesis

I. Barbash, D. Dvir, A. Pichard, 2012 .

A First-inMan , Randomized , Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome

P. Fitzgerald, N. Weissman, H. Brewer, 2022 .

Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis.

S. Epstein, K. Kent, A. Pichard, 2011, The American journal of cardiology.

Repeat Intracoronary Radiation for Recurrent In-Stent Restenosis in Patients Who Failed Intracoronary Radiation

K. Kent, A. Pichard, L. Satler, 2003, Circulation.

Clinical outcomes of first- and second-generation drug-eluting stents in patients undergoing rotational atherectomy for heavily calcified coronary lesions.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

The effect of complete percutaneous revascularisation with and without intravascular ultrasound guidance in the drugeluting stent era.

A. Pichard, L. Satler, R. Torguson, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3-Stent Generations

A. Pichard, L. Satler, R. Torguson, 2014, Circulation. Cardiovascular interventions.

Incidence, predictors, and outcome of new, subsequent lesions treated with percutaneous coronary intervention in patients presenting with myocardial infarction.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Stroke Complicating Percutaneous Coronary Interventions: Incidence, Predictors, and Prognostic Implications

N. Weissman, G. Mintz, K. Kent, 2002, Circulation.

Safety and feasibility of performing staged non-culprit vessel percutaneous coronary intervention within the index hospitalization in patients with ST-segment elevation myocardial infarction and multivessel disease.

K. Kent, A. Pichard, L. Satler, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2008, The American journal of cardiology.

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions

A. Pichard, L. Satler, R. Torguson, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A propensity score matched analysis to determine if second-generation drug-eluting stents outperform first-generation drug-eluting stents in a complex patient population.

A. Pichard, L. Satler, R. Torguson, 2013, International journal of cardiology.

Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty.

K. Kent, A. Pichard, L. Satler, 2009, Cardiovascular revascularization medicine : including molecular interventions.

Response to letter regarding article, "Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations".

A. Pichard, L. Satler, R. Torguson, 2015, Circulation. Cardiovascular interventions.

Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulation.

K. Kent, A. Pichard, L. Satler, 2011, The American journal of cardiology.

Safety and in-hospital outcomes of bivalirudin use in dialysis patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Safety and efficacy of bivalirudin for percutaneous coronary intervention with rotational atherectomy.

K. Kent, A. Pichard, L. Satler, 2010, Journal of interventional cardiology.

Transfer distance effect on reperfusion: timeline of ST-elevation patients transferred for primary percutaneous coronary intervention.

I. Barbash, A. Pichard, L. Satler, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Use of emergency medical services expedites in-hospital care processes in patients presenting with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

A. Pichard, L. Satler, R. Torguson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock.

A. Pichard, L. Satler, R. Torguson, 2012, Cardiovascular revascularization medicine : including molecular interventions.

Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Can acute occlusion of the left anterior descending coronary artery produce a typical "takotsubo" left ventricular contraction pattern?

K. Kent, A. Pichard, L. Satler, 2009, American Journal of Cardiology.

An intravascular ultrasound classification of angiographic coronary artery aneurysms.

N. Weissman, G. Mintz, K. Kent, 2001, The American journal of cardiology.

Incidence, Morphology, Angiographic Findings, and Outcomes of Intramural Hematomas After Percutaneous Coronary Interventions: An Intravascular Ultrasound Study

N. Weissman, G. Mintz, K. Kent, 2002, Circulation.

Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation.

Y. Deychak, W. Suddath, P. Varghese, 2001, Annals of emergency medicine.

Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention.

N. Weissman, K. Kent, A. Pichard, 2003, American heart journal.

The impact of diabetes mellitus on outcome of patients undergoing transcatheter aortic valve replacement

I. Barbash, A. Pichard, L. Satler, 2015 .

Outcomes in diabetic versus nondiabetic patients who present with acute myocardial infarction and are treated with drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Comparison of baseline characteristics and one-year outcomes between African-Americans and Caucasians undergoing percutaneous coronary intervention.

A. Pichard, L. Satler, R. Wolfram, 2004, The American journal of cardiology.

Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents

K. Kent, A. Pichard, L. Satler, 2008 .

Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Frequency of Angina Pectoris After Percutaneous Coronary Intervention and the Effect of Metallic Stent Type.

A. Pichard, L. Satler, A. Steinvil, 2016, The American journal of cardiology.

Prognosis of asymptomatic coronary artery disease after percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2010, American Journal of Cardiology.

Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction.

K. Kent, A. Pichard, L. Satler, 2012, American Journal of Cardiology.

Qualitative comparison of coronary angiograms between 4 french catheters with an Advanced Cardiovascular Injection System and 6 french catheters with manual injection

A. Pichard, L. Satler, R. Torguson, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical experience with a novel intracoronary perfusion catheter to treat no-reflow phenomenon in acute coronary syndromes.

K. Kent, A. Pichard, L. Satler, 2010, Journal of interventional cardiology.

The clinical significance of hematocrit values before and after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, American heart journal.

Intravascular ultrasound assessment of angiographic filling defects in native coronary arteries: do they always contain thrombi?

N. Weissman, G. Mintz, K. Kent, 2004, Journal of the American College of Cardiology.

Comparison between Society of Thoracic Surgeons score and logistic EuroSCORE for predicting mortality in patients referred for transcatheter aortic valve implantation.

I. Barbash, K. Kent, A. Pichard, 2011, Cardiovascular revascularization medicine : including molecular interventions.

Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacement.

G. Lemesle, K. Kent, A. Pichard, 2010, The American journal of cardiology.

Correlates and Causes of Death in Patients With Severe Symptomatic Aortic Stenosis Who Are Not Eligible to Participate in a Clinical Trial of Transcatheter Aortic Valve Implantation

K. Kent, A. Pichard, L. Satler, 2010, Circulation.

Utility of radiologic review for noncardiac findings on multislice computed tomography in patients with severe aortic stenosis evaluated for transcatheter aortic valve implantation.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Use of IIb/IIIa inhibitors in patients with in‐stent restenosis treated with intracoronary γ‐radiation: Integrilin WRIST

K. Kent, A. Pichard, L. Satler, 2004, Catheterization and cardiovascular interventions.

Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2012, Journal of interventional cardiology.

Nuisance and alarming bleeding do not correlate with on-treatment platelet reactivity.

K. Kent, A. Pichard, L. Satler, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Intravascular ultrasonic study of gender differences in ruptured coronary plaque morphology and its associated clinical presentation.

N. Weissman, G. Mintz, K. Kent, 2007, American Journal of Cardiology.

Racial disparity with on-treatment platelet reactivity in patients undergoing percutaneous coronary intervention.

I. Barbash, A. Pichard, L. Satler, 2013, American heart journal.

Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2013, The American journal of cardiology.

Relation of body mass index to on-treatment (clopidogrel + aspirin) platelet reactivity.

K. Kent, A. Pichard, L. Satler, 2011, The American journal of cardiology.

Response to Letters Regarding Article, “Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?”

G. Lemesle, K. Kent, A. Pichard, 2011 .

Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.

A. Pichard, L. Satler, S. Collins, 2010, Journal of interventional cardiology.

Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors.

G. Lemesle, K. Kent, A. Pichard, 2010, European heart journal.

Management and outcomes of coronary artery perforation during percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era.

K. Kent, A. Pichard, L. Satler, 2009, American Journal of Cardiology.

Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Comparative intravascular ultrasound analysis of ostial disease in the left main versus the right coronary artery.

N. Weissman, G. Mintz, K. Kent, 2007, The Journal of invasive cardiology.

Outcomes in patients with intra-aortic balloon pump who met the same inclusion criteria in the PROTECT II (a prospective feasibility trial investigating the use of the impella recover LP 2.5 system in patients undergoing high risk percutaneous coronary intervention) Study

G. Lemesle, K. Kent, A. Pichard, 2009 .

Safety and efficacy of prasugrel use in patients undergoing percutaneous coronary intervention and anticoagulated with bivalirudin.

K. Kent, A. Pichard, L. Satler, 2013, American Journal of Cardiology.

Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?

G. Lemesle, K. Kent, A. Pichard, 2010, Cardiovascular revascularization medicine : including molecular interventions.

COMPLICATIONS AND OUTCOMES OF BALLOON AORTIC VALVULOPLASTY IN HIGH-RISK OR INOPERABLE PATIENTS

K. Kent, A. Pichard, L. Satler, 2010 .

Bivalirudin versus unfractionated heparin in patients undergoing percutaneous coronary intervention after acute myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2006, Cardiovascular revascularization medicine : including molecular interventions.

Safety and efficacy of clopidogrel reloading in patients on chronic clopidogrel therapy who present with an acute coronary syndrome and undergo percutaneous coronary intervention.

A. Pichard, L. Satler, R. Torguson, 2011, American Journal of Cardiology.

Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, American heart journal.

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.

K. Kent, A. Pichard, L. Satler, 2009, American Journal of Cardiology.

Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions.

G. Lemesle, K. Kent, A. Pichard, 2009, American heart journal.

Use of naloxone during cardiac arrest and CPR: potential adjunct for postcountershock electrical-mechanical dissociation.

J. Rosborough, W. Suddath, J. Niemann, 1984, Annals of emergency medicine.

The influence of lipid-containing plaque composition assessed by near-infrared spectroscopy on coronary lesion remodelling.

A. Pichard, L. Satler, R. Torguson, 2016, European heart journal cardiovascular Imaging.

Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Abstract 4542: Does Proton Pump Inhibitor Use Following Percutaneous Coronary Intervention With Drug-eluting Stents Impact Clinical Outcome?

K. Kent, A. Pichard, L. Satler, 2009 .

Association between bleeding severity and long-term mortality in patients experiencing vascular complications after percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2012, The American journal of cardiology.

Volumetric intravascular ultrasound evidence that distal embolization during acute infarct intervention contributes to inadequate myocardial perfusion grade.

N. Weissman, G. Mintz, A. Pichard, 2003, American Journal of Cardiology.

Inappropriate use of risk score models for operative mortality in nonsurgical treatments

R. Torguson, W. Suddath, Petros G. Okubagzi, 2012 .

Insurance Type Inﬂuences the Use of Drug-Eluting Stents

A. Pichard, L. Satler, S. Collins, 2022 .

Impact of smoking on acute phase outcomes of myocardial infarction

K. Kent, A. Pichard, L. Satler, 2011, Coronary Artery Disease.

Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

In vivo virtual histology intravascular ultrasound comparison of neointimal hyperplasia within drug-eluting- versus bare metal stents.

N. Weissman, G. Mintz, K. Kent, 2011, The Journal of invasive cardiology.

Peri-stent reference segment plaque burden is associated with disease progression in saphenous vein grafts (a serial intravascular ultrasound assessment).

N. Weissman, G. Mintz, K. Kent, 2007, The American journal of cardiology.

Impact of previous coronary artery bypass grafting on patients undergoing transcatheter aortic valve implantation for aortic stenosis.

I. Barbash, D. Dvir, K. Kent, 2014, The American journal of cardiology.

Usefulness of preprocedural coronary lesion morphology as assessed by intravascular ultrasound in predicting Thrombolysis In Myocardial Infarction frame count after percutaneous coronary intervention in patients with Q-wave acute myocardial infarction.

N. Weissman, G. Mintz, A. Pichard, 2003, The American journal of cardiology.

Cardiovascular events in patients with coronary plaque rupture and nonsignificant stenosis.

N. Weissman, G. Mintz, K. Kent, 2005, The American journal of cardiology.

Right Atrial Pressure: Can It Be Ignored When Calculating Fractional Flow Reserve and Collateral Flow Index?

N. Weissman, K. Kent, A. Pichard, 2016 .

Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?

K. Kent, A. Pichard, L. Satler, 2007, Catheterization and cardiovascular interventions.

Left Ventricular Contraction Patterns in Patients With Suspected Acute Coronary Syndrome and Normal Coronary Angiograms: A New Look at the Takotsubo Syndrome

K. Kent, A. Pichard, L. Satler, 2011, Clinical cardiology.

Impact of drug-eluting stent type on periprocedural myocardial necrosis.

K. Kent, A. Pichard, L. Satler, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

CORONARY ARTERY DISEASE Impact of Bivalirudin Use on Outcomes in Nonagenarians Undergoing Percutaneous Coronary Intervention

G. Lemesle, K. Kent, A. Pichard, 2009 .

Reversal of pulmonary hypertension after percutaneous closure of congenital renal arteriovenous fistula in a 74-year old woman.

F. Asch, Gaby Weissman, W. Suddath, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

The late open-coronary artery hypothesis: dead, or not definitively tested?

S. Epstein, K. Kent, A. Pichard, 2007, American Journal of Cardiology.

Images in cardiovascular medicine. Spontaneous coronary dissection: computed tomography appearance and insights from intravascular ultrasound examination.

N. Weissman, K. Kent, A. Pichard, 2006, Circulation.

Intravascular ultrasound assessment of spontaneous coronary artery dissection.

N. Weissman, G. Mintz, K. Kent, 2002, The American journal of cardiology.

Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?

K. Kent, A. Pichard, L. Satler, 2010, American heart journal.

Outcomes of patients with acute myocardial infarction rom a saphenous vein graft culprit undergoing percutaneous coronary intervention

K. Kent, A. Pichard, L. Satler, 2011, Catheterization and cardiovascular interventions.

Safety and long‐term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus

A. Pichard, L. Satler, R. Torguson, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2011, Journal of interventional cardiology.

Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions.

M. Jeong, Y. Ahn, N. Weissman, 2010, The American journal of cardiology.

Impact of in-stent restenosis on death and myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Comparison between sirolimus‐ and paclitaxel‐eluting stents in complex patient and lesions subsets

K. Kent, A. Pichard, R. Torguson, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Intravascular ultrasound evidence of perivascular trauma during routine percutaneous coronary intervention

N. Weissman, G. Mintz, K. Kent, 2014, The International Journal of Cardiovascular Imaging.

Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2008, American Journal of Cardiology.

The influence of advancing age on implantation of drug‐eluting stents

A. Pichard, L. Satler, R. Torguson, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Relation of plaque morphology to thrombolysis in myocardial infarction flow in acute myocardial infarction determined by intravascular ultrasound.

N. Weissman, G. Mintz, K. Kent, 2003, American Journal of Cardiology.

Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2004, The American journal of cardiology.

Vascular complications following coronary intervention correlate with long‐term cardiac events

K. Kent, A. Pichard, L. Satler, 2004, Catheterization and cardiovascular interventions.

Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH--a multicenter clinical trial.

K. Kent, L. Satler, R. Wolfram, 2006, The Journal of invasive cardiology.

Incidence and correlates in the development of iatrogenic femoral pseudoaneurysm after percutaneous coronary interventions.

A. Pichard, L. Satler, R. Torguson, 2014, Journal of interventional cardiology.

The impact of diabetes mellitus on long-term clinical outcomes after percutaneous coronary saphenous vein graft interventions in the drug-eluting stent era.

A. Pichard, L. Satler, R. Torguson, 2014, Journal of interventional cardiology.

Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Contemporary Use of Veno-Arterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock in Acute Coronary Syndrome.

A. Pichard, L. Satler, R. Torguson, 2016, The Journal of invasive cardiology.

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Impact of overlapping drug‐eluting stents in patients undergoing percutaneous coronary intervention

K. Kent, A. Pichard, L. Satler, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety and efficacy of everolimus-eluting stents compared with first-generation drug-eluting stents in patients undergoing primary percutaneous coronary intervention.

A. Pichard, L. Satler, R. Torguson, 2014, Cardiovascular Revascularization Medicine.

In-Stent Restenosis of Drug-Eluting Stents Compared With a Matched Group of Patients With De Novo Coronary Artery Stenosis.

L. Satler, R. Torguson, R. Waksman, 2018, The American journal of cardiology.

Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2004, American Journal of Cardiology.

Determinants of angiographically silent stenoses in patients with coronary artery disease.

N. Weissman, G. Mintz, K. Kent, 2003, American Journal of Cardiology.

Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft.

K. Kent, A. Pichard, L. Satler, 2003, American heart journal.

Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device.

K. Kent, A. Pichard, L. Satler, 2005, The American journal of cardiology.

Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents

K. Kent, A. Pichard, L. Satler, 2006, Circulation.

Marked malapposition and aneurysm formation after sirolimus-eluting coronary stent implantation.

N. Weissman, K. Kent, A. Pichard, 2004, Circulation.

Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients.

N. Weissman, K. Kent, A. Pichard, 2006, The Journal of invasive cardiology.

Utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention for type C lesions.

K. Kent, A. Pichard, L. Satler, 2012, Journal of interventional cardiology.

Comparison of Bleeding Outcomes After Percutaneous Coronary Intervention in Patients With Versus Without Aortic Stenosis.

A. Pichard, L. Satler, R. Torguson, 2015, American Journal of Cardiology.

Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.

K. Kent, A. Pichard, L. Satler, 2005, The Journal of invasive cardiology.

The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?

N. Weissman, K. Kent, A. Pichard, 2002, Journal of the American College of Cardiology.

Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease

K. Kent, A. Pichard, L. Satler, 2007, Circulation.

Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients.

T. L. Pinto, K. Kent, A. Pichard, 2006, The American journal of cardiology.

IMAGE CARDIO MED: Percutaneous closure of a left ventricular outflow tract pseudoaneurysm causing extrinsic left coronary artery compression by transseptal approach.

K. Kent, L. Satler, S. Goldstein, 2010, Circulation.

Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome.

N. Weissman, A. Pichard, L. Satler, 2005, The American journal of cardiology.

A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome.

P. Fitzgerald, N. Weissman, H. Brewer, 2010, Journal of the American College of Cardiology.

Percutaneous coronary intervention‐associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine

K. Kent, A. Pichard, L. Satler, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Treatment of drug‐eluting stent restenosis with the same versus different drug‐eluting stent

K. Kent, A. Pichard, L. Satler, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis.

Gary S Mintz, Ron Waksman, N. Weissman, 2009, JACC. Cardiovascular imaging.

Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.

G. Lemesle, K. Kent, A. Pichard, 2009, Archives of cardiovascular diseases.

Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions.

G. Lemesle, K. Kent, A. Pichard, 2008, The American journal of cardiology.

The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention

K. Kent, A. Pichard, L. Satler, 2013, Catheterization and cardiovascular interventions.

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.

N. Weissman, K. Kent, A. Pichard, 2008, European heart journal.

Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials.

A. Pichard, L. Satler, R. Torguson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Endovascular recanalization of central venous access to allow for pacemaker implantation or upgrade.

K. Kent, A. Pichard, L. Satler, 2012, Cardiovascular revascularization medicine : including molecular interventions.

Sirolimus‐eluting stents and calcified coronary lesions: Clinical outcomes of patients treated with and without rotational atherectomy

K. Kent, A. Pichard, L. Satler, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Intravascular ultrasound assessment of the stenoses location and morphology in the left main coronary artery in relation to anatomic left main length.

R Waksman, G. Mintz, K. Kent, 2001, The American journal of cardiology.

Safety and efficacy of everolimus-eluting stents for bare-metal in-stent restenosis.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

The impact of cardiovascular risk factors on subclinical left main coronary artery disease: an intravascular ultrasound study.

N. Weissman, G. Mintz, K. Kent, 2006, American heart journal.

Impact of three or more sirolimus‐eluting stents versus paclitaxel‐eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention

K. Kent, A. Pichard, L. Satler, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.

K. Kent, A. Pichard, L. Satler, 2005, The American journal of cardiology.

Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2010, American Journal of Cardiology.

Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction.

Joseph Lindsay, Kohei Wakabayashi, Ron Waksman, 2010, The American journal of cardiology.

Correlation between light transmission aggregometry, VerifyNow P2Y12, and VASP-P platelet reactivity assays following percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2011, Journal of interventional cardiology.

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?

G. Lemesle, K. Kent, A. Pichard, 2010, Circulation.

Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2004, Cardiovascular revascularization medicine : including molecular interventions.

Intravascular Ultrasound Analysis of Infarct‐Related and Non‐Infarct‐Related Arteries in Patients Who Presented With an Acute Myocardial Infarction

Gary S Mintz, John R Laird, Ron Waksman, 2003, Circulation.

Cellular video-phone assisted transmission and interpretation of prehospital 12-lead electrocardiogram in acute st-segment elevation myocardial infarction.

A. Pichard, L. Satler, R. Torguson, 2011, Journal of interventional cardiology.

Relation of Sex and Race to Outcomes in Patients Undergoing Percutaneous Intervention With Drug-Eluting Stents.

W. Weintraub, L. Satler, R. Torguson, 2019, The American journal of cardiology.

Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Two-year follow-up of outcomes of second-generation everolimus-eluting stents versus first-generation drug-eluting stents for stenosis of saphenous vein grafts used as aortocoronary conduits.

I. Barbash, D. Dvir, K. Kent, 2013, The American journal of cardiology.

Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention.

K. Kent, A. Pichard, L. Satler, 2006, Journal of interventional cardiology.

Percutaneous interventions in patients with cocaine‐associated myocardial infarction: A case series and review

S. Ellahham, J. Lindsay, W. Suddath, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Negative remodeling and calcified plaque in octogenarians with acute myocardial infarction: an intravascular ultrasound analysis.

N. Weissman, G. Mintz, K. Kent, 2006, Journal of the American College of Cardiology.

Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound.

Akiko Maehara, Gary S Mintz, John R Laird, 2002, Journal of the American College of Cardiology.

Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Intravascular ultrasound findings in patients with restenosis of sirolimus- and paclitaxel-eluting stents.

N. Weissman, G. Mintz, K. Kent, 2008, International journal of cardiology.

The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents.

Kyung-Sook Park, Gary S Mintz, Ron Waksman, 2008, The American journal of cardiology.

Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysis.

N. Weissman, G. Mintz, K. Kent, 2006, The American journal of cardiology.

An intravascular ultrasound analysis of the mechanisms of restenosis comparing drug-eluting stents with brachytherapy.

N. Weissman, G. Mintz, K. Kent, 2006, American Journal of Cardiology.

Underexpansion of sirolimus‐eluting stents: Incidence and relationship to delivery pressure

N. Weissman, K. Kent, A. Pichard, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical, angiographic, and intravascular ultrasound characteristics of early saphenous vein graft failure.

N. Weissman, G. Mintz, A. Pichard, 2004, Journal of the American College of Cardiology.

Safety of percutaneous coronary intervention alone in symptomatic patients with moderate and severe valvular aortic stenosis and coexisting coronary artery disease: analysis of results in 56 patients.

N. Weissman, K. Kent, A. Pichard, 2004, The Journal of invasive cardiology.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Late thrombosis after gamma‐brachytherapy

N. Weissman, G. Mintz, K. Kent, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Coronary perfusion pressure and left ventricular hemodynamics as predictors of cardiovascular collapse following percutaneous coronary intervention.

L. Satler, R. Torguson, R. Waksman, 2019, Cardiovascular Revascularization Medicine.

Impact of intravascular ultrasound-guided direct stenting on clinical outcome of patients treated for native coronary disease.

N. Weissman, K. Kent, A. Pichard, 2004, Cardiovascular radiation medicine.

Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy.

K. Kent, A. Pichard, L. Satler, 2005, Cardiovascular revascularization medicine : including molecular interventions.

Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.

T. L. Pinto, K. Kent, A. Pichard, 2006, Cardiovascular revascularization medicine : including molecular interventions.

Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2008, Cardiovascular revascularization medicine : including molecular interventions.

Role of near-infrared spectroscopy in intravascular coronary imaging.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular Revascularization Medicine.

Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Clinical Outcomes and Treatment After Drug-Eluting Stent Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis

K. Kent, A. Pichard, L. Satler, 2012, Circulation. Cardiovascular interventions.

Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Synergistic increase risk of death and myocardial infarction at one year in patients with concomitant diabetes mellitus and renal failure

A. Pichard, L. Satler, S. Collins, 2010 .

Procedural results and outcomes after extensive stent coverage with drug-eluting stent implantation in single coronary lesions.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Comparison of long-term outcomes between everolimus-eluting and sirolimus-eluting stents in small vessels.

I. Barbash, D. Dvir, K. Kent, 2013, The American journal of cardiology.

Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents.

I. Barbash, D. Dvir, K. Kent, 2013, The American journal of cardiology.

Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents.

K. Kent, A. Pichard, L. Satler, 2011, American Journal of Cardiology.

Intravascular ultrasound analysis of the impact of gamma radiation therapy on the treatment of saphenous vein graft in-stent restenosis.

N. Weissman, G. Mintz, K. Kent, 2002, The American journal of cardiology.

Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Repeated stenting of recurrent in-stent restenotic lesions: intravascular ultrasound analysis and clinical outcome.

N. Weissman, G. Mintz, A. Pichard, 2007, The Journal of invasive cardiology.

Comparison of Rotational Atherectomy, Plain Old Balloon Angioplasty, and Cutting-Balloon Angioplasty Prior to Drug-Eluting Stent Implantation for the Treatment of Heavily Calcified Coronary Lesions.

A. Pichard, L. Satler, R. Torguson, 2015, The Journal of invasive cardiology.

Erratum to “Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?" (Cardiovasc Revasc Med 2010;11(2):91–7)

G. Lemesle, K. Kent, A. Pichard, 2011 .

Does on‐ versus off‐hours presentation impact in‐hospital outcomes of ST‐segment elevation myocardial infarction patients transferred to a tertiary care center?

A. Pichard, L. Satler, S. Collins, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis.

G. Mintz, K. Kent, A. Pichard, 2004, The American journal of cardiology.

Comparative efficacy of gamma-irradiation for treatment of in-stent restenosis in saphenous vein graft versus native coronary artery in-stent restenosis: An intravascular ultrasound study.

G. Mintz, K. Kent, A. Pichard, 2002, Circulation.

CLINICAL OUTCOMES FOLLOWING UNRESTRICTED USE OF THE EVEROLIMUS-ELUTING STENT AS COMPARED WITH PACLITAXEL- AND SIROLIMUS-ELUTING STENTS

K. Kent, A. Pichard, L. Satler, 2011 .

Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Changes in mitral regurgitation after balloon aortic valvuloplasty.

I. Barbash, K. Kent, A. Pichard, 2011, The American journal of cardiology.

Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis.

A. Pichard, L. Satler, R. Torguson, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abstract 13675: The Impact of Major Vascular Complications on the Long-Term Outcome for Patient Undergoing Trans-Catheter Aortic Valve Replacement

I. Barbash, L. Satler, R. Torguson, 2014 .

Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Long‐term safety and efficacy of second‐generation everolimus‐eluting stents compared to other limus‐eluting stents and bare metal stents in patients with acute coronary syndrome

A. Pichard, L. Satler, R. Torguson, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety and efficacy of the XIENCE V everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice.

I. Barbash, D. Dvir, K. Kent, 2012, The American journal of cardiology.

DOES MILD AORTIC REGURGITATION IN PATIENTS POST-TRANSCATHETER AORTIC VALVE REPLACEMENT IMPACT MORTALITY?

A. Pichard, L. Satler, R. Torguson, 2014 .

Real‐world clinical practice of intracoronary radiation therapy as compared to investigational trials

K. Kent, A. Pichard, L. Satler, 2005 .

Population characteristics, treatment assignment, and clinical outcome of patients with severe aortic stenosis who were not eligible to participate in a clinical trial evaluation percutaneous aortic valve replacement

K. Kent, A. Pichard, L. Satler, 2009 .

Percutaneous coronary intervention with drug‐eluting stents in octogenarians: Characteristics, clinical presentation, and outcomes

N. Weissman, K. Kent, A. Pichard, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparative Efficacy of γ-Irradiation for Treatment of In-Stent Restenosis in Saphenous Vein Graft Versus Native Coronary Artery In-Stent Restenosis

N. Weissman, G. Mintz, K. Kent, 2002 .

Spontaneous coronary artery dissection in a patient with systemic lupus erythematosis.

R. Virmani, A. Farb, A. Ajani, 2003, Hawaii medical journal.

TRANSCATHETER AORTIC VALVE IMPLANTATION UNDER CONSCIOUS SEDATION VERSUS GENERAL ANESTHESIA WITH INTUBATION

K. Kent, A. Pichard, L. Satler, 2010 .

HIGH TRANSVALVULAR GRADIENT VERSUS LOW TRANSVALVULAR GRADIENT IN PATIENTS WITH SEVERE AORTIC STENOSIS AND POOR LEFT VENTRICULAR FUNCTION

K. Kent, A. Pichard, L. Satler, 2011 .

Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy.

N. Weissman, K. Kent, A. Pichard, 2004, Cardiovascular radiation medicine.

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Abstract 4456: The Impact of Nuisance Bleeding on Clopidogrel Compliance in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

K. Kent, A. Pichard, L. Satler, 2008 .

Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis.

N. Weissman, G. Mintz, K. Kent, 2009, JACC Cardiovascular Imaging.

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Impact of smoking on acute phase outcomes of myocardial infarction

K. Kent, A. Pichard, L. Satler, 2011, Coronary artery disease.

Does creatine kinase‐MB (CK‐MB) isoenzyme elevation following percutaneous coronary intervention with drug‐eluting stents impact late clinical outcome?

K. Kent, A. Pichard, L. Satler, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.

A. Pichard, L. Satler, S. Collins, 2010, Journal of interventional cardiology.

Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, International journal of cardiology.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.